Advanced Pathology Solutions $30M Settlement Puts Lean Labs And Special Stains In The Medicare Kickback Ledger

BadPD source-check, June 20, 2026; source dates June 17-18, 2026: The U.S. Department of Justice says Advanced Pathology Solutions PLLC, APS MSO LLC, and current and former owners Kevin Hannah, Donell Burkett, and Daniel Hunter Pledger agreed to pay $30 million to resolve allegations that the Arkansas pathology laboratory furnished unlawful kickbacks and ordered medically unnecessary pathology testing services.

This is a public-money health-care accountability story because the source trail is not only about a lab billing dispute. DOJ says the alleged model involved gastroenterology practices, Medicare, TRICARE, the Department of Veterans Affairs, alleged referral inducements, and pathology tests that the government says were not medically reasonable or necessary.

What DOJ Says Was Resolved

DOJ’s June 17 release says APS was an anatomic pathology laboratory headquartered in North Little Rock, Arkansas, with a management services organization called APS MSO. The government complaint alleged that from 2015 through July 2022, APS and its owners violated the False Claims Act by providing unlawful kickbacks to gastroenterology practices to induce referrals of pathology testing to APS.

The complaint focused on what DOJ calls “lean labs”: limited-purpose laboratories that APS allegedly set up and managed inside gastroenterology practices nationwide. According to DOJ, those lean labs allowed the practices to bill for preparing and staining biopsy specimen slides, while the slides were shipped to APS’s North Little Rock lab for pathologist interpretation and review.

The accountability issue is the alleged trade: DOJ says APS furnished benefits to gastroenterology practices, and those practices allegedly agreed to exclusively refer patients to APS. That makes the case a useful BadPD receipt for the line between legitimate lab-management support and referral arrangements that federal health-care programs treat as kickback risk.

Special Stains, Confirmatory Tests, And ENFD Referrals

DOJ also says APS and its owners submitted or caused claims for unnecessary testing. The release says APS directed lean-lab personnel to automatically order certain “special stains” before a pathologist reviewed a routine hematoxylin and eosin stain to decide whether more testing was necessary.

The government alleged that the special-stain protocol caused APS and lean labs to order tests that were not medically reasonable and necessary and were ineligible for Medicare coverage or reimbursement. DOJ says APS also ordered additional confirmatory immunohistochemical testing on samples received from lean labs, which the government alleged was not medically necessary.

The settlement also resolves a separate allegation involving Richard Sorgnard and epidermal nerve fiber density, or ENFD, testing. DOJ says that from Nov. 1, 2018, to Nov. 30, 2020, APS and CEO Kevin Hannah knowingly and willfully paid Sorgnard volume-based commissions to induce referrals of patients to APS for ENFD testing. The settlement agreement says Sorgnard was paid 4% of payments APS collected for ENFD testing referred through medical providers, including payments from or on behalf of Medicare, VA, and TRICARE.

The Settlement Paper Trail

The DOJ release and HHS-OIG listing state the $30 million headline settlement and name APS, APS MSO, Kevin Hannah, Donell Burkett, and Daniel Hunter Pledger. The DOJ settlement agreement BadPD reviewed is narrower in one important way: it is the agreement among the United States, APS Entities, Kevin Hannah, and relators Brian Watkins, Denise Aucoin, Brent Aucoin, and Michael Paulsen.

That agreement requires the APS Entities and Hannah to pay $24 million to the United States, including $12 million in restitution. It allocates $22.5 million to the lean-lab actions and $1.5 million to the ENFD allegations. It also says CMS suspended Medicare payments to Advanced Pathology Solutions on July 26, 2024, and that the suspended amount was approximately $12,586,476 as of June 2, 2026. APS agreed that those suspended funds would be retained and applied first to Medicare overpayments and then to the settlement amount.

The agreement sets a five-year payment schedule, with interest accruing at 4.375% per year from April 14, 2026, on the unpaid amount not covered by the suspended funds. It also says Denise Aucoin is to receive 16.77% of each payment, including a proportionate share of interest, and distribute the share among Watkins and the Aucoin relators under their separate co-sharing agreement.

Confirmed, Alleged, Pending

Confirmed by official records: DOJ announced a $30 million total settlement; HHS-OIG lists the enforcement action; the DOJ release identifies APS, APS MSO, Kevin Hannah, Donell Burkett, and Daniel Hunter Pledger; the DOJ settlement agreement reviewed by BadPD covers the APS Entities and Hannah at $24 million; the agreement identifies Medicare, TRICARE, and VA claims; CMS had suspended about $12.586 million in Medicare payments as of June 2; APS entered a five-year Corporate Integrity Agreement with HHS-OIG.

Alleged or settlement posture: kickbacks to gastroenterology practices, exclusive-referral arrangements, medically unnecessary special stains, medically unnecessary confirmatory immunohistochemical testing, ENFD commission payments to Sorgnard, Anti-Kickback Statute violations, and False Claims Act liability remain settlement allegations. The agreement says it is not an admission of liability, the United States does not concede its claims were not well founded, and the defendants deny the allegations.

Missing records to verify: separate Burkett and Pledger settlement terms if filed separately, payment proof, full Corporate Integrity Agreement text, annual CIA reports, independent review findings, the full April 2026 complaint-in-intervention, docket entries in the Watkins, Aucoin, Paulsen, and APS payment-suspension cases, practice-by-practice lean-lab lists, affected federal-program payment totals, patient-notice records if any, and any follow-on action involving gastroenterology practices that used the model.

BadPD Bottom Line

The Advanced Pathology Solutions settlement belongs in the BadPD ledger because it ties a lab-management business model to public health-care billing and to the practical question behind every kickback case: who decided what the patient needed, and who got paid when the referral moved?

The follow-up is records-based. BadPD will watch for the CIA text, settlement payment proof, docket updates, and any public record showing whether the lean-lab referral model changed, whether unsupported testing was clawed back, and whether the gastroenterology practices involved face separate compliance consequences.

Source Trail

• DOJ USAO WDPA: Arkansas Pathology Laboratory and Its Owners Pay $30M to Settle Allegations (June 17, 2026; updated June 18, 2026) – Primary DOJ release with total settlement amount, lean-lab allegations, special-stain testing allegations, ENFD/Sorgnard allegations, CIA terms, and no-liability posture.
• DOJ APS settlement agreement PDF (June 2026) – Primary settlement agreement for the APS Entities and Kevin Hannah, including $24M payment terms, CMS suspended-payment treatment, relator share, covered conduct, denials, and reserved claims.
• HHS-OIG enforcement action: Arkansas pathology laboratory settlement (June 17, 2026) – Official OIG enforcement listing identifying Advanced Pathology Solutions, APS MSO, Kevin Hannah, Donell Burkett, and Daniel Hunter Pledger.
• KATV: Arkansas pathology lab owners to pay $30M to settle kickback allegations (June 17, 2026) – Local Arkansas report summarizing the complaint, lean-lab model, special stains, Sorgnard commission allegations, and corporate-integrity provisions.
• Becker's ASC: Arkansas lab pays $30M to settle kickback allegations tied to GI practices (June 2026) – Industry report adding gastroenterology-practice context and repeating the settlement/no-determination posture.